PM-1 (PM-Scl) Antibody
Histoplasma capsulatum Nucleic Acid Detection, Molecular Method
ABO Group and Rh Typing
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
SMAD4 Germline Mutation Analysis
Lymphocyte proliferation panel, Blood
Galactosemia
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Blood

LDS
Sign up
Log in

LDS
/Medical Tests
/Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
Medical Test

Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.